We are live on
!
Find out more
PSC
Prentiss Smith & Co Portfolio holdings
AUM
$182M
Turnover
8.7%
1-Year Est. Return
26.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$191M
AUM Growth
+$14.8M
(+8.4%)
Cap. Flow
+$4.27M
Cap. Flow
% of AUM
2.23%
Top 10 Holdings %
Top 10 Hldgs %
47.22%
Holding
271
New
28
Increased
29
Reduced
43
Closed
22
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
F5
FFIV
|
+$5.25M |
| 2 |
UMPQ
Umpqua Holdings Corp
UMPQ
|
+$4.89M |
| 3 |
Oracle
ORCL
|
+$2.77M |
| 4 |
First Solar
FSLR
|
+$2.04M |
| 5 |
Gilead Sciences
GILD
|
+$467K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magna International
MGA
|
+$7.44M |
| 2 |
WFM
Whole Foods Market Inc
WFM
|
+$3.12M |
| 3 |
Eli Lilly
LLY
|
+$1.33M |
| 4 |
CERN
Cerner Corp
CERN
|
+$834K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$766K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.37% |
| 2 | Technology | 20.77% |
| 3 | Communication Services | 15.92% |
| 4 | Industrials | 11.33% |
| 5 | Financials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
SolarEdge
SEDG
$1.93B
| $14K | 0.01% |
+700
| New | +$12.4K |
2017 Q2
0 quarters
|
|
177
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $14K | 0.01% |
+334
| New | +$13.6K |
2017 Q2
0 quarters
|
|
|
VSM
178
DELISTED
Versum Materials, Inc.
VSM
| $14K | 0.01% |
425
| – | – |
2016 Q4
2 quarters
|
|
179
Hewlett Packard
HPE
$77.8B
| $13K | 0.01% |
1,031
-345
| -25% | -$4.8K |
2015 Q4
6 quarters
|
|
180
Tesla
TSLA
$1.43T
| $13K | 0.01% |
525
-300
| -36% | -$6.6K |
2014 Q4
10 quarters
|
|
181
iShares Russell 2000 ETF
IWM
$77.5B
| $12K | 0.01% |
+85
| New | +$11.8K |
2017 Q2
0 quarters
|
|
182
Motorola Solutions
MSI
$75.5B
| $12K | 0.01% |
142
| – | – |
2017 Q1
1 quarter
|
|
|
BGCA.CL
183
DELISTED
BGC Partners, Inc.
BGCA.CL
| $12K | 0.01% |
450
| – | – |
2015 Q3
7 quarters
|
|
|
HSEB.CL
184
DELISTED
HSBC Holdings plc
HSEB.CL
| $12K | 0.01% |
450
| – | – |
2015 Q3
7 quarters
|
|
185
American Airlines Group
AAL
$8.13B
| $11K | 0.01% |
209
| – | – |
2016 Q4
2 quarters
|
|
186
iShares National Muni Bond ETF
MUB
$49.2B
| $11K | 0.01% |
+101
| New | +$11.1K |
2017 Q2
0 quarters
|
|
187
Ionis Pharmaceuticals
IONS
$7.33B
| $10K | 0.01% |
200
| – | – |
2013 Q2
16 quarters
|
|
188
MetLife Inc Floating Rate Series A
MET.PRA
$507M
| $10K | 0.01% |
397
| – | – |
2016 Q4
2 quarters
|
|
189
Oaktree Specialty Lending
OCSL
$1.04B
| $10K | 0.01% |
667
| – | – |
2013 Q2
16 quarters
|
|
190
ResMed
RMD
$34.1B
| $10K | 0.01% |
125
| – | – |
2014 Q4
10 quarters
|
|
191
Synaptics
SYNA
$4.67B
| $10K | 0.01% |
200
| – | – |
2016 Q4
2 quarters
|
|
192
Union Bankshares
UNB
$113M
| $10K | 0.01% |
200
| – | – |
2017 Q1
1 quarter
|
|
193
Invesco DB Commodity Index Tracking Fund
DBC
$1.97B
| $9K | ﹤0.01% |
+642
| New | +$9.42K |
2017 Q2
0 quarters
|
|
194
Fiserv Inc
FISV
$25.1B
| $9K | ﹤0.01% |
150
| – | – |
2014 Q4
10 quarters
|
|
195
HP
HPQ
$27.8B
| $9K | ﹤0.01% |
500
| – | – |
2013 Q2
16 quarters
|
|
196
Wave Life Sciences
WVE
$629M
| $9K | ﹤0.01% |
500
| – | – |
2016 Q2
4 quarters
|
|
197
DELISTED
Sun Trust Banks, Inc. Depositary Shares (1/4,000th Interest in Preferred Stock, Series A)
STI.PRA
| $9K | ﹤0.01% |
364
| – | – |
2016 Q4
2 quarters
|
|
198
Bank of America Depository Shares Series 5
BML.PRL
$314M
| $8K | ﹤0.01% |
330
| – | – |
2016 Q4
2 quarters
|
|
199
Wheaton Precious Metals
WPM
$60.5B
| $8K | ﹤0.01% |
400
| – | – |
2013 Q2
16 quarters
|
|
200
Goldman Sachs Group Inc Series D Preferred Stock
GS.PRD
$1.02B
| $7K | ﹤0.01% |
285
| – | – |
2016 Q4
2 quarters
|
|
Similar funds
TA
LAM
MPW
FNBOH
SIM
CAM
PW
DRC
Prentiss Smith & Co's Q2 2017 Portfolio in Review
As of Q2 2017, Prentiss Smith & Co held 271 positions worth $191M, up 8.4% from $176M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Prentiss Smith & Co's Q2 2017 filing shows 28 new, 29 increased, 43 reduced and 22 closed positions. Its largest new stake was Gilead Sciences: 7,018 shares worth $497K. The largest sale was Magna International, an estimated $7.44M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.
- Prentiss Smith & Co's largest Q2 2017 buy was Gilead Sciences: 7,018 shares worth $497K.
- Prentiss Smith & Co added most to F5 in Q2 2017, an estimated $5.25M increase.
- Prentiss Smith & Co's biggest Q2 2017 reduction was Whole Foods Market Inc, cutting an estimated $3.12M.
- Prentiss Smith & Co fully exited Magna International in Q2 2017, selling an estimated $7.44M.
- Prentiss Smith & Co's ten largest holdings make up 47% of its $191M portfolio in Q2 2017.
- Prentiss Smith & Co opened 28 new positions and closed 22 in Q2 2017.
- Prentiss Smith & Co's portfolio value rose 8.4% quarter-over-quarter to $191M.
Based on Prentiss Smith & Co's 13F filing for Q2 2017, filed 10 Jul 2017.